TSE:ACB Aurora Cannabis (ACB) Stock Price, News & Analysis C$3.85 +0.08 (+2.12%) As of 07/27/2026 04:00 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesBuy This Stock About Aurora Cannabis Stock (TSE:ACB) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Aurora Cannabis alerts:Sign Up Key Stats Today's RangeC$3.80▼C$3.9350-Day RangeC$3.64▼C$5.0652-Week RangeC$3.59▼C$9.33Volume390,468 shsAverage Volume397,297 shsMarket CapitalizationC$238.48 millionP/E RatioN/ADividend YieldN/APrice TargetC$7.17Consensus RatingBuy Company Overview Aurora Cannabis, headquartered in Edmonton, Canada, cultivates and sells medicinal and recreational cannabis through a portfolio of brands that includes Aurora, CanniMed, Daily Special, MedReleaf, and San Rafael '71. Although the company primarily operates in Canada, it has expanded internationally through medical cannabis exporting agreements or cultivation facilities in more than 20 countries. Read More Aurora Cannabis Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks54th Percentile Overall ScoreACB MarketRank™: Aurora Cannabis scored higher than 54% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.9 / 5Analyst RatingBuy Consensus RatingAurora Cannabis has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on no strong buy ratings, 3 buy ratings, no hold ratings, and no sell ratings.Upside PotentialAurora Cannabis has a consensus price target of C$7.17, representing about 86.1% upside from its current price of C$3.85.Amount of Analyst CoverageAurora Cannabis has only been the subject of 2 research reports in the past 90 days.Read more about Aurora Cannabis' stock forecast and price target. Earnings and Valuation0.6 / 5Proj. Earnings GrowthN/A Price to Earnings Ratio vs. the MarketThe P/E ratio of Aurora Cannabis is -1.80, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Aurora Cannabis is -1.80, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioAurora Cannabis has a P/B Ratio of 0.43. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities. Short InterestN/AShort Interest LevelN/A Short InterestThere is no current short interest data available for ACB. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldAurora Cannabis does not currently pay a dividend.Dividend GrowthAurora Cannabis does not have a long track record of dividend growth. News and Social Media3.7 / 5News Sentiment1.85 News SentimentAurora Cannabis has a news sentiment score of 1.85. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.91 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 2 news articles for Aurora Cannabis this week, compared to 1 article on an average week.Search InterestOnly 5 people have searched for ACB on MarketBeat in the last 30 days. This is a decrease of -17% compared to the previous 30 days. Company Ownership0.0 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Aurora Cannabis insiders have not sold or bought any company stock.Percentage Held by Institutions4.19% of the stock of Aurora Cannabis is held by institutions.Read more about Aurora Cannabis' insider trading history. Receive ACB Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Aurora Cannabis and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. ACB Stock News HeadlinesAurora Receives Support from Leading Independent Proxy Adviser Institutional Shareholder Services Inc. for the 2026 Annual General Meeting of ShareholdersJuly 27 at 8:00 AM | finance.yahoo.comSafari Flower Company, a Wholly Owned Subsidiary of Aurora Cannabis, Receives EU-GMP Certification at Niagara FacilityJuly 23, 2026 | finance.yahoo.comTrump's New DollarPorter Stansberry says President Trump has signed an executive order initiating what he calls a full U.S. dollar reset - and most Americans don't know it's happening. The last time America underwent a monetary shift like this, under Nixon in the 1970s, it minted an average of 1,300 new millionaires a day for over half a century. Stansberry has released a new documentary naming the assets he believes are positioned to surge as a result. | Porter & Company (Ad)Weekly Roundup on the Cannabis Sector & Psychedelic SectorJuly 13, 2026 | finance.yahoo.comAurora Named to TIME Canada's Best Companies 2026 ListJuly 9, 2026 | finance.yahoo.comAnalysts Have Conflicting Sentiments on These Healthcare Companies: Genmab (GMAB), Dianthus Therapeutics (DNTH) and Aurora Cannabis (ACB)June 16, 2026 | theglobeandmail.comAurora Cannabis Q4 2026 Earnings Call TranscriptJune 11, 2026 | benzinga.comPuff, puff, profit: Aurora Cannabis earns record revenue and adjusted EBITDAJune 11, 2026 | msn.comSee More Headlines ACB Stock Analysis - Frequently Asked Questions How have ACB shares performed this year? Aurora Cannabis' stock was trading at C$5.77 at the beginning of the year. Since then, ACB shares have decreased by 33.3% and is now trading at C$3.85. How were Aurora Cannabis' earnings last quarter? Aurora Cannabis Inc. (TSE:ACB) released its quarterly earnings results on Thursday, June, 11th. The company reported ($0.99) earnings per share (EPS) for the quarter. The business had revenue of $38.01 million for the quarter. Aurora Cannabis had a negative net margin of 12.13% and a negative trailing twelve-month return on equity of 7.25%. How do I buy shares of Aurora Cannabis? Shares of ACB stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers. What other stocks do shareholders of Aurora Cannabis own? Based on aggregate information from My MarketBeat watchlists, some other companies that Aurora Cannabis investors own include Canopy Growth (CGC), Canopy Growth (WEED), Aphria (APHA), Meta Platforms (META), NVIDIA (NVDA), Organigram (OGI) and Aurora Cannabis (ACBFF). Company Calendar Last Earnings6/11/2026Today7/27/2026Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeTSE SectorMedical Industry Drug Manufacturers - Specialty & Generic Sub-IndustryN/A Current SymbolTSE:ACB CIKN/A Webauroramj.com Phone+1-604-3625207FaxN/AEmployees1,073Year FoundedN/APrice Target and Rating Average Price Target for Aurora CannabisC$7.17 High Price TargetC$8.50 Low Price TargetC$5.00 Potential Upside/Downside+86.1%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage3 Analysts Profitability EPS (Trailing Twelve Months)C($2.14) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-C$44.16 million Net Margins-12.13% Pretax MarginN/A Return on Equity-7.25% Return on Assets-1.87% Debt Debt-to-Equity Ratio4.66 Current Ratio5.94 Quick Ratio2.48 Sales & Book Value Annual SalesC$320.59 million Price / Sales0.74 Cash FlowC$3.09 per share Price / Cash Flow1.25 Book ValueC$8.91 per share Price / Book0.43Miscellaneous Outstanding Shares61,942,000Free FloatN/AMarket CapC$238.48 million OptionableNot Optionable Beta0.27 Don't Wait for the OpenAI IPOThe AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.Get This Free Report This page (TSE:ACB) was last updated on 7/28/2026 by MarketBeat.com Staff. From Our PartnersMy top 3 AI picks for the next decadeAlexander Green bought Apple in 1996, recommended Nvidia at a split-adjusted 66 cents in 2004, and picked up A...The Oxford Club | SponsoredWhat Elon told his top shareholders in TexasLate last year, Elon Musk gathered top shareholders at Tesla's Texas Gigafactory to unveil a plan to double Am...Banyan Hill Publishing | SponsoredBuy this stock todayMarc Chaikin, founder of Chaikin Analytics, is sharing a strategy he calls 'Sell This, Buy That' - a way to mo...Chaikin Analytics | SponsoredYour book attachedBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...Profits Run | SponsoredA storm is comingThe U.S. dollar has sunk to near a four-year low, while the Bureau of Economic Analysis prepares a change to h...Stansberry Research | SponsoredUniversal basic income is not impossible. It exist (kind of)Robert Kiyosaki, author of Rich Dad Poor Dad, is highlighting an income strategy he calls the Patriot Income P...Freedom Financial | SponsoredThree oil giants buried the same discovery for 50 yearsIn 1976, Chevron tapped an energy source with no fuel costs, no carbon, and no supply chain - then killed the ...Behind the Markets | SponsoredBofA: Digital Dollar Coming 2025-2030Bank of America just revealed your expiration date. In their Bloomberg interview, they didn't just predict the...Decentralized Masters | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aurora Cannabis Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Aurora Cannabis With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
